Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine
Yearly influenza vaccination is recommended for patients with humoral primary immunodeficiency (hPID). However, humoral responses following vaccination can be expected to be reduced in these patients. The efficacy of influenza vaccination in patients with hPID, anti-influenza antibody responses was...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 136(2010), 2 vom: 15. Aug., Seite 228-35
|
|---|
| 1. Verfasser: |
van Assen, Sander
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Holvast, Albert,
Telgt, Denise S C,
Benne, Cornelis A,
de Haan, Aalzen,
Westra, Johanna,
Kallenberg, Cees G M,
Bijl, Marc |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2010
|
|---|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
|---|
| Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
Antibodies, Viral
Immunoglobulins, Intravenous
Influenza Vaccines
Vaccines, Subunit |
|---|